United States v. Scotia Pharmaceuticals Ltd.

33 Ct. Int'l Trade 638, 2009 CIT 49
CourtUnited States Court of International Trade
DecidedMay 20, 2009
DocketCourt 03-00658
StatusPublished

This text of 33 Ct. Int'l Trade 638 (United States v. Scotia Pharmaceuticals Ltd.) is published on Counsel Stack Legal Research, covering United States Court of International Trade primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Scotia Pharmaceuticals Ltd., 33 Ct. Int'l Trade 638, 2009 CIT 49 (cit 2009).

Opinion

OPINION AND ORDER

STANCEU, Judge:

Plaintiff United States brought this action under Section 592 of the Tariff Act of 1930, as amended, 19 U.S.C. § 1592 (1988), against defendants Scotia Pharmaceuticals Limited (“Scotia Pharmaceuticals”), Callanish Ltd. (“Callanish”), and Quantanova, Canada, Ltd. (“Quantanova”) on September 16, 2003. The government sought to recover a civil penalty for alleged violations of § 1592 by defendants arising out of fifty-three consumption entries of merchandise, made between September 1, 1988 and March 24, 1992, that *639 the government alleged to have been capsules of “evening primrose oil,” a substance used as a food additive that could not be imported lawfully at the time of the entries at issue. Of the three defendants, all of which are located outside of the United States, plaintiff successfully effected service of process only upon Callanish. Pl.’s Req. for Entry of Default 1. Because Callanish failed to appear by licensed counsel and failed to plead or otherwise defend itself within twenty days of being served with the summons and complaint, the Clerk of this Court, pursuant to USCIT Rules 12 and 55, entered Callanish’s default. Entry of Default 1.

On May 8, 2008, plaintiff applied for a judgment by default against Callanish in the amount of $17,734,926 pursuant to USCIT Rule 55(b). Pl.’s Req. for Default J. as to Callanish Ltd. 1-2 (“Pl.’s Req. for Default J.”). The government requested dismissal of defendants Scotia Pharmaceuticals and Quantanova because of its inability to effect service of process on those defendants. Id. at 1. Plaintiff did not submit, in support of its application for judgment by default, a complete record of the administrative penalty proceedings that were conducted before the United States Customs Service 1 (“Customs”) and that gave rise to this action. In October 2008, plaintiff supplemented its application with various documents related to those administrative proceedings and responded to certain questions the court earlier had raised concerning the application for judgment by default. Pl.’s Resp. to Court’s Aug. 21, 2008 Req. for Additional Information.

Upon review of the complaint and plaintiff’s application, the court holds that plaintiff has not established its entitlement to the judgment by default that it seeks against defendant Callanish for a civil penalty under 19 U.S.C. § 1592. The court, therefore, will deny plaintiff’s application but will also allow plaintiff the opportunity to amend its complaint. Because plaintiff has not effected service upon defendants Scotia Pharmaceuticals and Quantanova, the court grants plaintiff’s request to dismiss these defendants.

I. BACKGROUND

Beginning on February 12, 1985, the Food and Drug Administration (“FDA”) issued a series of import alerts announcing that evening primrose oil could not be sold lawfully in the United States without FDA approval, that this substance did not have FDA approval, and that all import shipments of evening primrose oil offered for entry *640 into the United States were to be detained by Customs. Pl.’s Req. for Default J. 4. Plaintiff’s complaint alleges that during the period of September 1, 1988 through March 24, 1992, defendants violated 19 U.S.C. § 1592 by participating in a fraudulent scheme to introduce evening primrose oil into the United States through various ports of entry by means of material false statements, documents, acts and/or material omissions and are jointly and severally liable for a civil penalty under § 1592. Compl. ¶¶ 6-9, 21-22. Plaintiff alleges that defendants, as part of this scheme, knowingly provided false invoices to “Health Products International and/or Pine Lawn Farms in order to conceal from Customs the identity of the merchandise being imported and the identity of the true parties to the transactions.” Id. at ¶ 11.

Plaintiff’s complaint does not allege the identity of the party who filed entry documents with Customs for the fifty-three entries allegedly used to import evening primrose oil. The complaint, however, does allege that the documents filed with respect to those entries were false in multiple respects. The complaint alleges, specifically, that: (1) the entry documentation falsely described the merchandise as “edible capsules of vegetable oil” or “edible oil capsules with alpha-tocopheryl,” or used similar designations, and in several instances stated that the merchandise was “for use [as] a vitamin supplement for cattle” or “not for human consumption,” when in fact the merchandise was evening primrose oil intended for human consumption and prohibited by the FDA as an unsafe food additive within the meaning of 21 U.S.C. §§ 342 and 348 (1988); (2) the buyers of the merchandise falsely were identified as “Genesis II of Mid America, Inc.” (on thirteen of the subject entries) and “Pine Lawn Farms, Inc.” (on forty of the entries) although the true buyer was “Health Products International;” (3) the sellers of the merchandise falsely were identified as “Pineridge Ltd.” (on thirteen of the entries), “B.V. Handelmij Comme-lin,” (on thirty-seven of the entries) and Callanish (on three of the entries), when in fact the true seller was Efamol Limited (“Efamol”) or its successor, Scotia Pharmaceuticals; and (4) for thirty-seven of the consumption entries, the entry documents falsely identified the country of origin as the Netherlands rather than the true origin, the United Kingdom. Id. ¶¶ 12-15.

Customs conducted an administrative penalty proceeding under 19 U.S.C. § 1592(b) against defendants prior to bringing this action. See id. ¶ 17. On or about August 18, 1997, Customs issued pre-penalty notices to defendants or their predecessors in interest. Id. The pre-penalty notices provided defendants with notice that Customs was considering a civil penalty equal to the domestic value of the evening primrose oil, which Customs believed to include fifty-three consump *641 tion entries, for a total domestic value of $18,019,436. Id. ¶¶ 17, 22. On or about March 19, 2001, Customs issued to defendants or their predecessors in interest an administrative penalty notice demanding a monetary penalty in the amount of $18,019,436. Id. ¶ 17. The complaint alleges that defendants did not pay any part of the assessed penalty. Id. ¶ 18.

Plaintiff commenced this action on September 16, 2003. Summons 2. Because all three defendants are located outside of the United States, plaintiff attempted to procure service upon them pursuant to the Hague Convention on the Service Abroad of Judicial and Extrajudicial Documents. See Pl.’s Status Report 1, Dec. 5, 2003.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
33 Ct. Int'l Trade 638, 2009 CIT 49, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-scotia-pharmaceuticals-ltd-cit-2009.